Pharmacology, Toxicology and Pharmaceutical Science
Cross-Sectional Study
100%
Adenovirus Vector
88%
Syndrome
88%
Thrombocytopenia
88%
Thrombosis
88%
Sodium Valproate
88%
Imatinib
88%
Prevalence
62%
Risk Communication
53%
Cohort Study
47%
Pharmacology
44%
Drug Approval
44%
Community Pharmacy
44%
Overall Survival
44%
Polypharmacy
44%
Pharmacovigilance
44%
Antihypertensive
44%
Observational Study
44%
Temozolomide
44%
Mouth Cancer
44%
Capecitabine
44%
Haemophilus Influenzae Type B Vaccine
44%
Pharmaceutical Manufacturing
44%
Respiratory Tract Disease
44%
Cardiovascular System Cancer
44%
Combination Therapy
44%
Erlotinib
29%
Fludarabine
29%
COVID-19 Vaccine
17%
Biosimilar Agent
14%
Placebo
11%
Physical Disease by Body Function
8%
Side Effect
8%
Cross Sectional Study
6%
Medicine and Dentistry
Awareness
88%
Tonsillopharyngitis
44%
Population Size
44%
Imatinib
44%
Sodium Valproate
44%
Cross Sectional Study
44%
Clinical Decision Making
44%
Cervical Cancer Screening
44%
Antibiotics
35%
Fludarabine
29%
Pharmacovigilance
22%
Health Behavior
22%
Prevalence
17%
Biosimilar
14%
Health Care Cost
14%
Head
14%
Colposcopy
14%
Cervical Cancer
14%
Upper Respiratory Tract Infection
8%
Personal Experience
8%
Haemophilus Influenzae Type B Vaccine
7%
Combination Therapy
7%
Self-Diagnosis
7%
Respiratory Disease
7%
Cardiovascular System Cancer
7%
Nursing and Health Professions
General Practitioner
96%
Health Care Personnel
88%
Practice Guideline
50%
Patient Preference
44%
Survey Method
44%
Reimbursement
44%
Valproic Acid
44%
Capecitabine
44%
Temozolomide
44%
Imatinib
44%
Mouth Cancer
44%
Healthcare System
12%
Neurologist
7%
Cross-Sectional Study
7%
Thematic Analysis
6%
Health Care Practice
6%
Upper Respiratory Tract Infection
6%
Clinical Decision Making
6%